Spread of multidrug resistant Acinetobacter baumannii in a teaching hospital

Tunisie Medicale

Volumn 86, Issue 4, 2008, Pages 312-315

  Hammami, Samia ^a   Ghozzi, Rafiaa ^a   Ben Redjeb, Saida ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Acinetobacter baumannii; Intensive care units; Multidrug resistant; Outbreak

Indexed keywords

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD SAMPLING; DISK DIFFUSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NONHUMAN; PUS; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY SYSTEM; TEACHING HOSPITAL; URINALYSIS; ACINETOBACTER INFECTION; CROSS INFECTION; EPIDEMIC; TUNISIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; TUNISIA;

EID: 67549107225     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4328-35.
2. Bou G, Cervero G, Dominguez Ma, Quereda C, Martinez-Beltran J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol. 2000;38:3299-305.
3. Bergogne-Berezin E, Towner Kj. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996 ;9:148-65.
4. Campbell M, Mahenthiralingam E, Speert Dp. Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa. J Clin Microbiol. 2000 ;38:4614-5.
5. Afzal-Shah M, Woodford N, Livermore Dm. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2001;45:583-8.
6. Yan Jj, Hsueh Pr, Ko Wc et al. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother. 2001 ;45:2224-8.
7. Hsueh Pr, Chen Ml, Sun Cc et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis. 2002 ;8:63-8.
8. Elaichouni A, Verschraegen G, Claeys G, Devleeschouwer M, Godard C, Vaneechoutte M. Pseudomonas aeruginosa serotype O12 outbreak studied by arbitrary primer PCR. J Clin Microbiol. 1994;32:666-71.
9. Crespo Mp, Woodford N, Sinclair A et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol. 2004 ;42:5094-101.
10. Higgins Pg, Wisplinghoff H, Stefanik D, Seifert H. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2004;48:1586-92.
11. Gales Ac, Jones Rn, Forward Kr, Linares J, Sader Hs, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis. 2001; 32 (Suppl 2): S104-13.
12. Wilks M, Wilson A, Warwick S et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol. 2006 ;27:654-8.
13. Afzal-Shah M, Livermore Dm. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother. 1998 ;41:576-7.
14. Corbella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000 ;38:4086-95.
15. Koeleman Jg, Stoof J, Biesmans Dj, Savelkoul Ph, Vandenbroucke-Grauls Cm. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii. J Clin Microbiol. 1998 ;36:2522-9.
16. Seifert H, Schulze A, Baginski R, Pulverer G. Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol. 1994 ;32:1816-9.